David Roman
Stock Analyst at Goldman Sachs
(2.09)
# 2,929
Out of 4,960 analysts
45
Total ratings
44%
Success rate
-3.32%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARL Carlsmed | Initiates: Buy | $19 | $13.41 | +41.69% | 1 | Aug 18, 2025 | |
| OMDA Omada Health | Initiates: Buy | $29 | $21.29 | +36.21% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $88.46 | +17.57% | 3 | Jun 4, 2025 | |
| BBNX Beta Bionics | Initiates: Neutral | $16 | $17.15 | -6.71% | 1 | May 30, 2025 | |
| PODD Insulet | Initiates: Buy | $380 | $327.88 | +15.90% | 1 | May 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $80 → $50 | $66.96 | -25.33% | 3 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $120 → $104 | $107.71 | -3.44% | 2 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Buy | $13 → $10 | $7.60 | +31.67% | 4 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $94 → $82 | $74.12 | +10.63% | 3 | May 1, 2025 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $24 → $23 | $17.98 | +27.96% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $132.23 | +16.46% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $12.01 | +99.83% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $72.85 | -2.54% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $56.57 | -2.78% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $24.50 | +71.43% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $91 → $124 | $167.78 | -26.09% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $390.67 | +9.30% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $81.64 | +10.24% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $105.95 | -15.05% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $472.79 | +5.76% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $195.76 | +39.97% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $92.15 | -9.93% | 1 | May 30, 2024 |
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $13.41
Upside: +41.69%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $21.29
Upside: +36.21%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $88.46
Upside: +17.57%
Beta Bionics
May 30, 2025
Initiates: Neutral
Price Target: $16
Current: $17.15
Upside: -6.71%
Insulet
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $327.88
Upside: +15.90%
Doximity
May 21, 2025
Maintains: Neutral
Price Target: $80 → $50
Current: $66.96
Upside: -25.33%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $107.71
Upside: -3.44%
Teladoc Health
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.60
Upside: +31.67%
GE HealthCare Technologies
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $74.12
Upside: +10.63%
Kestra Medical Technologies
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $17.98
Upside: +27.96%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $132.23
Upside: +16.46%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $12.01
Upside: +99.83%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $72.85
Upside: -2.54%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $56.57
Upside: -2.78%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $24.50
Upside: +71.43%
Feb 24, 2025
Maintains: Neutral
Price Target: $91 → $124
Current: $167.78
Upside: -26.09%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $390.67
Upside: +9.30%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $81.64
Upside: +10.24%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $105.95
Upside: -15.05%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $472.79
Upside: +5.76%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $195.76
Upside: +39.97%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $92.15
Upside: -9.93%